Medical device maker Medtronic is advising doctors and patients to pay close attention to all malfunction alarms on implantable SynchroMed II drug pumps because of a problem that has caused a handful ...
Medtronic is updating the software for its SynchroMed implantable infusion pumps due to a software issue that could cause the devices to deliver too much or too little of a drug. The action is deemed ...
Medtronic’s SynchroMed II implantable drug pump device, which has been recalled three times in recent years and tied to 14 deaths, has continued to be problematic for the medtech company. A three-page ...
The Food and Drug Administration (FDA) has approved design changes and a new programming interface for Medtronic's SynchroMed II implantable drug pump, months after federal authorities lifted sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback